2018 annual financial data

Chemomab Therapeutics Ltd. 2018 Operating margin

Chemomab Therapeutics Ltd. 2018 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was 12,658,000 USD and net income was 13,279,000 USD.
Operating cash flow was -14,176,786 USD.

Get free Chemomab Therapeutics Ltd. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
12,658,000 USD
Net income
13,279,000 USD
Operating cash flow
-14,176,786 USD